Logo Image
News
Latest NewsFDA NewsAdverse Event ManagementSupportive CareDisparities in Cancer CareDrug SafetyRadiation OncologySurvivorship Practice ManagementPreventionContributorsSponsored
Media
Expert ConnectionsTranslating TrialsCase-Based Peer PerspectivesPodcastsVideosShorts
Conferences
Conference CoverageConference Listing
Publications
More
CME/CE
Continuing Education
Resources
Case-Based Digest Rx Road MapEventsAdvanced Practice Corner
Partners

Subscribe

  • News
  • Media
  • Conferences
  • Publications
  • CME/CE
  • Resources
  • Subscribe
  • Partners
  • Brain Cancer
  • Breast Cancer
    • Metastatic Breast Cancer
  • Gastrointestinal Cancer
    • Colorectal Cancer
    • Liver Cancer
    • Gastric Cancers
  • Genitourinary Cancer
    • Kidney Cancer
    • Bladder Cancer
    • Prostate Cancer
  • Gynecologic Cancers
    • Endometrial Cancer
    • Cervical Cancer
    • Ovarian Cancer
  • Head and Neck Cancers
  • Hematology
    • Leukemia
    • Graft-Vs-Host Disease
    • Myeloproliferative Neoplasms
    • Multiple Myeloma
    • Lymphoma
  • Lung Cancer
  • Pediatric Cancer
  • Sarcomas
  • Skin Cancer
    • Melanoma
Advertisement

Erin Wallace

Advertisement

Articles by Erin Wallace

Study Finds Regional Disparities in Access to Specialist Gynecologic Cancer Care

ByErin Wallace
July 21st 2015

Women living in certain areas of the United States may face health risks due to their limited access to specialized gynecologic cancer care.

Advertisement

Latest Updated Articles

  • Study Finds Regional Disparities in Access to Specialist Gynecologic Cancer Care
    Study Finds Regional Disparities in Access to Specialist Gynecologic Cancer Care

    July 21st 2015



Advertisement
Advertisement

Trending on Oncology Nursing News

1

FDA Approves Camizestrant for ESR1-Mutated Advanced Breast Cancer

2

Thoracic Oncology Advances and Toxicity Management

3

FDA Approves Zanidatamab-hrii in GEA: Key Takeaways for Oncology Nurses

4

ASCO Releases First Living Guideline for Recurrent Ovarian Cancer Care

5

First-Line Treatment Choice and Altering Resistance in EGFR-Mutant NSCLC

  • About Us
  • Editorial Board
  • Contact Us
  • CancerNetwork.com
  • CureToday.com
  • OncLive.com
  • TargetedOnc.com
  • Advertise
  • Privacy
  • Terms & Conditions
  • Do Not Sell My Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us